ArticleJournal of Parkinson's disease2026

A monoclonal antibody-based immunoassay reinforces DOPA decarboxylase in cerebrospinal fluid as a diagnostic biomarker for Parkinson's disease with potential prognostic value.

Hubert Aviolat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.